# Understanding Ketamine's Dissociative Effects (KD Study)

> **NCT04861051** · PHASE1 · RECRUITING · sponsor: **Stanford University** · enrollment: 20 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT04861051
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-26
- **Primary completion:** 2028-08-01
- **Final completion:** 2028-08-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04861051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04861051, "Understanding Ketamine's Dissociative Effects (KD Study)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04861051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*